ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study
WILMINGTON, Del., July 15 /PRNewswire/ -- ParagonRx, a healthcare consulting leader in risk management and the appropriate use of drugs, has filed its interim analysis
of a study that shows how its proprietary approach to risk management can help manufacturers of opioid drugs meet FDA standar...
Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
BETHLEHEM, Pa. and NEWTON, Mass., June 30 /PRNewswire/ -- Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTC Bulletin Board: MFLU), and Particle Sciences Inc. (PSI) have formed a strategic alliance to help biopharmaceutical companies leverage the most advanced...
A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
GORLITZ, Germany, June 18 /PRNewswire/ -- 2009 is the year of the 40th
anniversary since the introduction of the worldwide first fluorescence based
flow cytometer - the ICP 11.
Today, the German biotechnology company celebrates this anniversary at
the Saxonian State Vineyard Castle Wack...
Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data
Boston Biotech Firm Reports First Rise in 76 Years of Replikin Count* of H1N1 Lethality Gene
BOSTON, June 10 /PRNewswire/ -- An analysis
of the latest peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of H1N1 is increasing in its capacity for lethali...
Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins
ANN ARBOR, Mich., June 1 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced the release of the first commercially available multiplex assay dedicated to the analysis
of heat sho...
Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
TUSTIN, Calif., May 29 /PRNewswire/ -- Exiqon Diagnostics, announced today a strategic commercial partnership with MedTrust Online, an innovative, comprehensive internet based solution provider for oncologists that offers clinically useful knowledge on the latest topics in cancer treatment. Exiqo...
International science consortium publishes analysis of domestic cattle genome sequence
The U.S. Department of Agriculture and the National Institutes of Health announced today that an international consortium of researchers has published the genome of domestic cattle, the first livestock mammal to have its genetic blueprint sequenced and analyzed. The landmark research will bolster ...
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Large Cardiovascular Outcomes Study To Be Initiated
Manufacturing Comparability Analysis
Complete: Exenatide Once Weekly NDA Submission Remains On Track
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), El...
New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
AGAWAM, Mass., March 16 /PRNewswire/ -- Contamination by mycoplasmal organisms is an ever-present concern in biopharmaceutical manufacturing. Their properties make them ready sources of contamination, while rendering them difficult and time-consuming to detect. A new free white paper, examines how...
GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools
GERMANTOWN, Md., March 5 /PRNewswire/ -- GeneCopoeia announces the launch of a suite of miRNA functional analysis
reagents and tools. They include 1) miExpress(TM) vector based precursor miRNA expression clones; 2) miTarget(TM) miRNA target sequence (3' UTR) expression clones; and 3) All-in-One(TM...
BioNanomatrix's Revolutionary Whole Genome Analysis Platform Named to MIT Technology Review's Annual 10 Emerging Technologies List
-Company's Goal Is to Lower the Cost of Genome Analysis
to $100 In Order To Make Genomic Information Universally Available for Routine Medical Care-
PHILADELPHIA, Feb. 24 /PRNewswire/ -- BioNanomatrix, Inc., a developer of breakthrough whole genome imaging and analysis
platforms for biomedica...
New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy
Comprehensive review demonstrates bioidentical hormones are superior to synthetic HRT with greater cardiovascular benefits and reduced risk of breast cancer
TORRANCE, Calif., Feb. 23 /PRNewswire/ -- The most comprehensive analysis
to date, published in the Postgraduate Medical Journal, a lead...
Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile
NOVATO, Calif., Feb. 12 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical
Inc. (Nasdaq: BMRN ) announced today that in the first interim efficacy
analysis (IEA) for the Riquent(R) Phase 3 ASPEN trial, the Independent Data
Monitoring Board (DMB) determined that the continuation of the trial i...
Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
-- New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy --
MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced t...
Maximize Data Analysis with METTLER TOLEDO FBRM
METTLER TOLEDO FBRM® provides an information-rich method for tracking the number and dimension of particles or droplets as they actually exist in process. In any given particle system, there are specific and possibly unique, changes that are of critical importance to the user. This three pa...
REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial (Proceedings of ASCO GI Symposium 2009)
SAN MARINO, Calif., Jan. 20 /PRNewswire/ -- Epeius Biotechnologies ( www.epeiusbiotech.com ) announced the results of a U.S. Phase I/II study evaluating the safety and efficacy of Rexin-G in chemotherapy-resistant metastatic pancreatic cancer (ASCO GI Symposium, #249; Sant P Chawla, P.I., Santa ...
New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development
SCOTTSDALE, Ariz., Dec. 2 /PRNewswire/ -- MedPredict Market Research, a
global provider of pharmaceutical competitive intelligence and market
research, has published a new report providing critical strategic insight for
pharma and biotech companies with a stake in the market for Parkinson's
Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
SAN MATEO‚ Calif.‚ Nov. 10 /PRNewswire/ -- Corthera Inc. today
announced that an interim analysis
of top-line data from Pre-RELAX-AHF, the
Phase II portion of a Phase II/III multicenter, randomized, double-blind,
international study, showed favorable efficacy and safety for relaxin, the
Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts
Global calorimeters and thermal analysis
equipment market is poised to exceed $539 million by 2012. Consumables, life sciences, drug discovery and automation of analytical tools are few lucrative areas that are expected to drive the industry's growth in the coming years.
Interim Analysis of Data from e-HEALING Registry of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
Sigmund Silber to Highlight 12-Month Patient Subset Results in Oral Presentation
HONG KONG, Nov. 7 /PRNewswire/ -- An interim analysis
patient subset data from e-HEALING, a global post-marketing surveillance
registry of OrbusNeich's Genous Bio-enginee...
Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
- Sale Reinforces Strategic Focus and Enhances Cash Position -
HOPKINTON, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for
drug discovery and life sciences research, today announced that it has
reached an a...
Plexon Inc Delivers 500th "Harvey Box" : 25 Years of Neural Data Acquisition and Analysis Leads to 500th System Sale
Plexon Inc, Dallas-based maker of neurotechnology research systems, announced the sale of its 500th Multi-Channel Acquisition Processor (MAP) system since the company was founded in 1983.
DALLAS (Business Wire EON) October 20, 2008 -- The MAP system, or "Harvey B...
Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies
EXTON, Pa., Oct. 20 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex:
ILE) announced today that the Company will host an investor conference call
and webcast on Wednesday, October 22 at 4:30 PM Eastern Time to present an
analysis of the data from the Isolagen Therapy(TM) Phase III pivotal
Process Safety and Thermal Hazard Analysis Fall Webinar Series presented by METTLER TOLEDO
METTLER TOLEDO is pleased to announce that Dr. Francis Stoessel, a leading Process Safety Consultant with the Swiss Safety Institute (SWISSI), will be the Keynote Speaker in the Process Safety and Thermal Hazard Analysis
Columbia, MD (PRWEB) October 1, 2...
Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Separate Retrospective Analysis
of Phase 3 Data Offers Additional
Information on Bazedoxifene Alone
COLLEGEVILLE, Pa., Sept. 25 /PRNewswire/ -- A retrospective analysis
Phase 3 two-year data presented at the annual meeting of the North American
Menopause Society (NAMS) suggest that postme...
TIBCO Spotfire and INTEGROMICS Announce Genomics Data Analysis Solution to Radically Speed Drug Research and Development
Spotfire Platform Evolves with INTEGROMICS to Lead the Industry in
Advancing Life Sciences Research, Discovery and Development
SOMERVILLE, Mass., Sept. 23 /PRNewswire-FirstCall/ -- TIBCO Software
Inc. (Nasdaq: TIBX ), together with INTEGROMICS, a provider of
state-of-the-art software soluti...
Xceed Ziplex(R) System for Automated Gene-Expression Analysis Wins 2008 R&D 100 Award
WELLESLEY, Mass., Aug. 19 /PRNewswire/ -- Xceed Molecular, a pioneer in
the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that R&D Magazine has selected the company's Ziplex
System as a recipient of the magazine's prestigious R&D 100 Award. Called
BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
Toronto Stock Exchange Symbol: MS
- Milestone triggers $10 million payment from Eli Lilly and Company - EDMONTON, Aug. 13 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX:
MS), a leading developer in the treatment of multiple sclerosis (MS), today
announced that the independent Drug Safety ...
Ingenuity Systems Launches Analysis Services
REDWOOD CITY, Calif., Aug. 5 /PRNewswire/ -- Ingenuity Systems, the
leading provider of information solutions for life science researchers,
today introduced Ingenuity Analysis
Services, custom-tailored professional
scientific services for scientists working with 'omics data related to
Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
WASHINGTON and WELLESLEY, Mass., July 29 /PRNewswire/ -- Xceed
Molecular, a pioneer in the development of cost-effective, easy-to-use
systems, will launch its new Inflammation Xpress
Chip, a pre-configured array for use with the company's Ziplex automated
Sophisticated soil analysis for improved land use
Soil variation occurs across multiple geographic scales ranging from vast climatic regions of the Earth to a 50 acre farm field to the molecular world of soil nano-particles in a pinch of soil.
For example, in a forest or an agricultural field, soil properties vary from the summit of a hill do...
HealthEast Care System Selects Concuity's ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
VERNON HILLS, Ill. and DUBLIN, Ireland, April 21 /PRNewswire-FirstCall/
-- Concuity, a healthcare division of Trintech (Nasdaq: TTPA ) and a leading
provider of contract management and revenue recovery technology ("Peer
Reviewed by HFMA") and services, today announced that HealthEast Care
Squire Sanders Stands Out in Independent Analysis of Law Firms in Europe
The Legal 500 EMEA 2008 Confirms Squire Sanders' Position as Market Leader
LONDON, April 17 /PRNewswire/ -- Global law firm Squire, Sanders &
Dempsey L.L.P. has received a glowing review across a range of offices and
practice areas in the highly respected independent legal guide The Legal
Amnis Announces Release of Powerful New Image Data Analysis Software
SEATTLE, April 10 /PRNewswire/ -- Amnis Corporation announced today a
major new release of its IDEAS(R) statistical image analysis
IDEAS version 3.0 incorporates greatly expanded analytical capabilities
while maintaining an emphasis on ease of use.
IDEAS 3.0 provides the user with ...
Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
CENTER VALLEY, Pa., April 4, 2008 /PRNewswire/ -- Scientists in fields
as diverse as pharmaceutical research, food science and biology will
benefit from the Olympus FluoroPoint(TM) single molecule fluorescence
detection system for molecular interaction analysis. Already in use in
scores of lab...
HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
-Agreement provides Lilly researchers broad access to HistoRx AQUA(R) technology for tissue biomarker analysis-
NEW HAVEN, Conn., March 26 /PRNewswire/ -- HistoRx, Inc. announced
today that it has signed a three-year agreement with Eli Lilly and Company
(NYSE: LLY ) to make the...
New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
PALO ALTO, Calif., March 10 /PRNewswire-FirstCall/ -- Varian, Inc.
(Nasdaq: VARI ) announced today its new XSens(TM) Dual Cold Probe. Designed
for use with the Varian NMR System, the new probe is Varian's most
sensitive probe for 13C detected NMR experiments.
The XSens Probe offers producti...
Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
Pharsight's Regulatory-Oriented Consulting Unit to Use Pharsight
Knowledgebase Server for Management of Pre-Clinical and Clinical Data
MOUNTAIN VIEW, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Pharsight
Corporation (Nasdaq: PHST ), a leading provider of software, strategic
New Glycobiology Analysis Manual 2nd Edition Provides Valuable Resource for Novices and Experts in the Field
ST. LOUIS, Feb. 21 /PRNewswire-FirstCall/ -- Sigma-Aldrich(R) (Nasdaq:
SIAL) announced the release of the Glycobiology Analysis
Edition: Tools for Glycoproteomics and Glycomics, a laboratory reference
for life science ( http://www.sigma.com/glycobook ).
Credit-card-sized platform for volatile compound analysis CAREER project goal
Blacksburg, Va. Developing a credit-card-sized gas chromatography platform that can analyze volatile compounds within seconds is the next step for Virginia Tech College of Engineering researcher Masoud Agah, who has received a National Science Foundation (NSF) Faculty Early Career Development Pro...